Zifang Guo
- Oncology top 5%
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 5
- Cancer Research top 10%
- Geochemistry and Petrology top 10%
-
- Advanced Breast Cancer Therapies 4
-
- Hepatitis C virus research 12
-
- HIV/AIDS drug development and treatment 10
-
- Chronic Lymphocytic Leukemia Research 3
-
- Statistical Methods and Inference 3
-
- HIV Research and Treatment 2
- Co-authors
- Javier CortésVassiliki KarantzaCarlos H. BarriosNorikazu MasudaMastura Md YusofSherene LoiMarco Torregroza OteroPeter Schmid
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Zifang Guo
28 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 653
- Cancer Research 235
- Immunology 204
- Geochemistry and Petrology 46
- Pulmonary and Respiratory Medicine 250
Countries citing papers authored by Zifang Guo
This map shows the geographic impact of Zifang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifang Guo more than expected).
Fields of papers citing papers by Zifang Guo
This network shows the impact of papers produced by Zifang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifang Guo. The network helps show where Zifang Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zifang Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 28 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 7 | |
| 6 | Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancerbreakdown → | 2022 | 594 |
| 7 | 2021 | 5 | |
| 8 | 2021 | 18 | |
| 9 | 2020 | 137 | |
| 10 | 2019 | 113 | |
| 11 | 2019 | 10 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 14 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 3 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 7 | |
| 18 | 2014 | 1 | |
| 19 | 2009 | 7 | |
| 20 | 2009 | 33 |
About Zifang Guo
Zifang Guo is a scholar working on Hepatology, Infectious Diseases and Statistics and Probability, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (10 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Statistical Methods and Inference (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Oncology (653 citations), Cancer Research (235 citations) and Immunology (204 citations). Zifang Guo has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Javier Cortés, Vassiliki Karantza, Carlos H. Barrios, Norikazu Masuda, Mastura Md Yusof, Sherene Loi, Marco Torregroza Otero, Peter Schmid, Seock‐Ah Im and Hope S. Rugo. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.